Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
Clinical trial NCT06562621 · COMPLETED
Trial details
- NCT number
- NCT06562621
- Sponsor
- Beijing Neurosurgical Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2022-08-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.